NuView Life Sciences in the News

Jun 06

0

NuView Partners With Aperture Bio on Prostate Cancer Test

By Karla Jo Helms | NuView Life Sciences in the News

NEW YORK (360Dx) — NuView Life Sciences has signed an agreement to evaluate its NV-VPAC1 urogenital cancer test on Aperture Bio’s screening platform, the company…

Better Solutions Needed As Cancer Drug Costs Escalate

https://bioprocessintl.com/business/economics/better-solutions-needed-cancer-drug-costs-escalate/

Aug 21

0

Investing in Precision Diagnostics Drives Down Cancer Treatment +Costs

http://moneyforlunch.com/investing-in-precision-diagnostics-drives-down-cancer-treatment-costs/

Aug 17

0

NuView to Launch Expanded Trials to Ready Prostate Cancer Test for FDA Clearance

https://www.360dx.com/regulatory-news/nuview-launch-expanded-trials-ready-prostate-cancer-test-fda-clearance

Jun 05

0

Precision-based medicine improves outcomes and drives down costs

https://www.dotmed.com/news/story/37261?utm_campaign=MagLink&utm_source=DMBusiness&utm_medium=print

May 19

0

Emerging Technologies for Precision-Based Cancer Diagnostics

https://www.mpo-mag.com/contents/view_online-exclusives/2017-05-19/emerging-technologies-for-precision-based-cancer-diagnostics/

May 17

0

As the Cost of Cancer Treatment Rises, Patients Pay the Price

https://www.medicaltourismmag.com/cost-cancer-treatment-rises-patients-pay-price/

Mar 01

0

Cancer Screening Tool Reduces Costs And Invasiveness

https://www.healthitoutcomes.com/doc/cancer-screening-tool-reduces-costs-and-invasiveness-0001

Feb 27

0

Black Men Are More Likely To Die Of Cancer Than Any Other Ethnic Group

http://www.mnialive.com/articles/black-men-are-more-likely-to-die-of-cancer-than-any-other-ethnic-group

Feb 15

0

HOW RADIOLOGISTS ARE HANDLING THE NUCLEAR MATERIALS SHORTAGE

https://www.healthleadersmedia.com/innovation/how-radiologists-are-handling-nuclear-materials-shortage

NuView Partners With Aperture Bio on Prostate Cancer Test

Better Solutions Needed As Cancer Drug Costs Escalate

Investing in Precision Diagnostics Drives Down Cancer Treatment +Costs

NuView to Launch Expanded Trials to Ready Prostate Cancer Test for FDA Clearance

Precision-based medicine improves outcomes and drives down costs

Emerging Technologies for Precision-Based Cancer Diagnostics

As the Cost of Cancer Treatment Rises, Patients Pay the Price

Cancer Screening Tool Reduces Costs And Invasiveness

Black Men Are More Likely To Die Of Cancer Than Any Other Ethnic Group

HOW RADIOLOGISTS ARE HANDLING THE NUCLEAR MATERIALS SHORTAGE

Categories

Recent Posts

Archives

Contact Address

Toll-Free: 888.902.7779
Office: 435.647.9758
Fax: 435.647.5602

The most recent press

Quick Links

NuView Life Sciences in the News

NuView Partners With Aperture Bio on Prostate Cancer Test

Better Solutions Needed As Cancer Drug Costs Escalate

Investing in Precision Diagnostics Drives Down Cancer Treatment +Costs

NuView to Launch Expanded Trials to Ready Prostate Cancer Test for FDA Clearance

Precision-based medicine improves outcomes and drives down costs

Emerging Technologies for Precision-Based Cancer Diagnostics

As the Cost of Cancer Treatment Rises, Patients Pay the Price

Cancer Screening Tool Reduces Costs And Invasiveness

Black Men Are More Likely To Die Of Cancer Than Any Other Ethnic Group

HOW RADIOLOGISTS ARE HANDLING THE NUCLEAR MATERIALS SHORTAGE

Categories

Recent Posts

Archives

Contact Address

Toll-Free: 888.902.7779 Office: 435.647.9758 Fax: 435.647.5602

The most recent press

Quick Links

Toll-Free: 888.902.7779
Office: 435.647.9758
Fax: 435.647.5602